bronchopulmonary dysplasia

Search with Google Search with Bing
Information
Disease name
bronchopulmonary dysplasia
Disease ID
DOID:11650
Description
"A lung disease that is characterized by underdeveloped lungs in newborns that can be easily irritated or inflamed after birth resulting in damage to the alveoli of the lungs and bronchi. Most newborns who develop BPD are born more than 10 weeks before their due dates, weigh less than 2 pounds at birth, and have breathing problems." [url:https\://www.nhlbi.nih.gov/health/bronchopulmonary-dysplasia]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02371460 Active, not recruiting Phase 3 Maternal Omega-3 Supplementation to Reduce Bronchopulmonary Dysplasia June 23, 2015 March 2025
NCT01353313 Active, not recruiting Phase 3 Hydrocortisone for BPD August 11, 2011 January 2025
NCT05404815 Active, not recruiting Exposure to Plasticisers in the Neonatal Intensive Care Unit June 2, 2020 December 30, 2023
NCT03540680 Active, not recruiting N/A p16Ink4a in Bronchopulmonary Dysplasia in Children March 7, 2018 December 30, 2023
NCT02475434 Active, not recruiting N/A Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants June 10, 2015 December 30, 2024
NCT05915806 Active, not recruiting N/A Enteral High-dose DHA Supplementation on Bronchopulmonary Dysplasia in Very Preterm Infants: a Collaborative Study July 30, 2023 March 2024
NCT04255147 Active, not recruiting Phase 1 Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia October 17, 2022 November 6, 2033
NCT01632475 Active, not recruiting Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia September 2011 September 2026
NCT04662151 Active, not recruiting Phase 1 A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD) September 1, 2021 May 23, 2024
NCT00515281 Active, not recruiting Phase 2/Phase 3 Inhaled Nitric Oxide and Neuroprotection in Premature Infants May 2008 June 7, 2023
NCT03808402 Active, not recruiting The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS October 26, 2018 March 30, 2025
NCT04560179 Active, not recruiting Phase 1 Inhaled Tobramycin in BPD March 22, 2022 December 31, 2024
NCT03231735 Active, not recruiting Phase 2/Phase 3 Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome August 2, 2017 October 31, 2024
NCT03782610 Active, not recruiting Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes April 1, 2019 June 2026
NCT03717584 Active, not recruiting A Cohort Study of the Intestinal Microbiota of Premature Infants December 23, 2018 December 2026
NCT00011362 Completed Phase 3 Dexamethasone Therapy in VLBW Infants at Risk of CLD September 1992 April 1994
NCT06082414 Completed Systemic Management in Extremely Preterm and Extremely Low Birth Weight Infants January 30, 2019 January 29, 2020
NCT00167544 Completed Phase 2 Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants November 2005 November 2012
NCT00188968 Completed Phase 3 Randomized Trial of Nasal Continuous Positive Airway Pressure or Synchronized Nasal Ventilation in Premature Infants. November 2004 February 2007
NCT00208039 Completed N/A Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates September 2004 November 2007
NCT00233324 Completed Phase 3 Surfactant Positive Airway Pressure and Pulse Oximetry Trial February 2005 August 2016
NCT00234247 Completed Prolonged Outcomes After Nitric Oxide (PrONOx) December 2002 November 2008
NCT00314431 Completed Phase 3 Post-hospitalization Nursing Effectiveness (PHONE) Study May 1996 August 2000
NCT00319956 Completed Phase 2 Trial II of Lung Protection With Azithromycin in the Preterm Infant September 2004 June 2012
NCT00419588 Completed Growth of Airways and Lung Tissues in Premature and Healthy Infants September 2006 January 2019
NCT00422305 Completed Assessment of Lung Structure and Function of Infants Born Prematurely January 2007 January 2019
NCT00428038 Completed Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease February 2004 December 2008
NCT00492102 Completed Phase 1 Montelukast in Very Low Birthweight Infants March 2007 June 2011
NCT00569530 Completed Phase 3 Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide January 2008 December 2012
NCT00623740 Completed Phase 3 PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates April 2008 January 2016
NCT05311228 Completed Phase 4 The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm Infant June 8, 2021 April 1, 2022
NCT00757146 Completed Neonatal Intensive Care (NICU) Course and Hospital Outcome of Infants With BPD Treated Using Inhaled Nitric Oxide March 2006 February 2010
NCT00840983 Completed Phase 1 Effects of Delayed Cord Clamping in Very Low Birth Weight Infants August 2003 December 2006
NCT05235399 Completed Right vEntricular Function Prediction mOdel to Identify pReterm infanTs With Early BronchoPulmonary Dysplasia. June 1, 2022 May 5, 2023
NCT00926276 Completed Phase 4 The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia June 2009 May 2013
NCT00931632 Completed Phase 3 Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants November 2009 May 2014
NCT00955487 Completed Phase 2 Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns January 2007 December 2014
NCT01006629 Completed Phase 2/Phase 3 Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children November 2009 July 2010
NCT01022580 Completed Phase 3 Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia January 2010 January 2016
NCT01035190 Completed Phase 3 Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia April 2010 July 2016
NCT01039285 Completed Phase 4 Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia December 2009 June 2022
NCT01124331 Completed N/A Appropriate Oxygen Levels for Extremely Preterm Infants: a Prospective Meta-analysis March 2005 August 2014
NCT01203358 Completed Phase 2/Phase 3 Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome January 1991 January 1992
NCT01203488 Completed Phase 1/Phase 2 Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants January 1996 July 1999
NCT05152875 Completed Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia March 21, 2022 May 31, 2022
NCT01223274 Completed Phase 1/Phase 2 Delivery Room CPAP in Extremely Low Birth Weight Infants July 2002 January 2003
NCT05152316 Completed The Baby Lung Study September 17, 2021 May 31, 2023
NCT01297205 Completed Phase 1 Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia December 2010 December 2011
NCT05082272 Completed The Role of Transthoracic Echocardiography in Diagnosis of Pulmonary Hypertension of Infants With Bronchopulmonary Dysplasia January 1, 2016 June 1, 2017
NCT05055193 Completed Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary Dysplasia January 1, 2013 December 31, 2018
NCT01383850 Completed Phase 2 NCPAP + Heliox as a Treatment for Infant Respiratory Distress Syndrome (RDS) February 2008 September 2010
NCT01424553 Completed N/A Respiratory Outcome at Adolescence of Very Low Birthweight Infants October 2011 April 2015
NCT01439295 Completed Ascorbyl Peroxide Association With Bronchopulmonary Dysplasia August 2010 November 2015
NCT01440647 Completed N/A Study of Nasal Ventilation In Preterm Infants To Decrease Time on The Respirator November 2007 January 2010
NCT01460576 Completed Improving Prematurity-Related Respiratory Outcomes at Vanderbilt September 2011 December 2016
NCT01473264 Completed Phase 1/Phase 2 Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS) January 2000 December 2003
NCT01600430 Completed Phase 2/Phase 3 Vitamin D Supplementation for Extremely Preterm Infants June 2012 December 2016
NCT01607216 Completed Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies August 2011 July 2015
NCT01644981 Completed Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia May 2012 December 2013
NCT01648855 Completed Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn June 2012 June 2016
NCT05036603 Completed N/A Comparison of the Acute Effects of Chest Physiotherapy Methods Applied in Different Positions in Preterm Newborns April 1, 2022 August 15, 2022
NCT01717625 Completed Phase 2 The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia November 2011 October 2013
NCT04941963 Completed Ultrasound Assessment of Diaphragmatic Function in Infants With BPD November 26, 2019 July 15, 2022
NCT01722760 Completed Tidal Neonatal NO, Vitamins A and D, and Infant Lung Disease - The AD-ON Study August 2013 November 2015
NCT01739114 Completed N/A Assessment of Lung Aeration at Birth May 2013 October 2014
NCT04936477 Completed N/A Ventilation-perfusion (V/Q) Ratio and Alveolar Surface Area in Preterm Infants September 29, 2020 January 30, 2023
NCT01748565 Completed Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia May 2012 August 2016
NCT01780155 Completed Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of Prematurity June 24, 2013 August 1, 2020
NCT01828957 Completed Phase 2 Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants April 2013 August 2015
NCT04792099 Completed N/A CPAP Or Nasal Cannula Oxygen for Preterm Infants: A Randomized Controlled Trial August 16, 2021 March 29, 2023
NCT01897987 Completed N/A Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial January 2014 March 2020
NCT01941745 Completed Phase 2 Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome October 2013 August 25, 2017
NCT01962818 Completed N/A High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Lung Volume Monitored by Electric Tomography Impedance. January 2014 January 1, 2023
NCT01996670 Completed Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS January 2007
NCT02023788 Completed Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study April 2014 October 2016
NCT04348799 Completed Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia January 1, 2019 January 1, 2020
NCT02083562 Completed Biomarkers and Volumetric Capnography in BPD November 2013 June 2018
NCT02102711 Completed N/A Oral Vitamin A Supplementation in Neonates With Birth Weight < 1500 g April 2014 April 2016
NCT02142621 Completed N/A Transpyloric Feeding in Severe Bronchopulmonary Dysplasia December 18, 2014 July 15, 2016
NCT02210026 Completed Phase 1 Seattle-PAP Bubble Nasal CPAP and Work of Breathing August 2014 October 2015
NCT02249143 Completed N/A Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants September 2014 September 2017
NCT04234152 Completed N/A Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study November 23, 2020 January 17, 2022
NCT02287116 Completed N/A Continuous Positive Airway Pressure Via Binasal Prong vs Nasal Mask: a Randomised Controlled Trial May 2014 October 2014
NCT02381366 Completed Phase 1/Phase 2 Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study March 2015 May 2018
NCT02443961 Completed Phase 1 Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies April 2, 2019 July 7, 2022
NCT02447250 Completed Phase 4 Preterm Infant Inhaled Albuterol Dosing October 24, 2013 December 30, 2014
NCT04191239 Completed Comparing Two Different Modes of Ventilation in Pretem Neonates Bilevel VG and PRVC January 1, 2021 June 30, 2021
NCT04163822 Completed Analysis of BPD in Premature Infants With Typical Imaging Changes January 1, 2020 May 20, 2021
NCT02527798 Completed Phase 2 Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD) November 27, 2015 October 15, 2019
NCT02723513 Completed N/A Bronchopulmonary Dysplasia: From Neonatal Chronic Lung Disease to Early Onset Adult COPD April 1, 2016 September 2020
NCT02729844 Completed Neolifes Heart - Pulmonary Hypertension in Preterm Children June 1, 2016 August 25, 2021
NCT02784821 Completed Phase 2 Antibiotic "Dysbiosis" in Preterm Infants January 16, 2017 September 11, 2019
NCT02788110 Completed N/A Work of Breathing During Non-invasive Ventilation in Premature Neonates August 2016 June 2018
NCT02819050 Completed N/A Effective Approaches & Strategies to Ease Off Nasal CPAP In Preterm Infants January 2014 January 2016
NCT02820818 Completed Pulmonary Outcomes of Bronchopulmonary Dysplasia in Young Adulthood June 2016 December 2021
NCT02921308 Completed Pulmonary MRI of Ex-preterm Children With and Without BPD To Understand Risk of Emphysematous Changes January 5, 2018 September 18, 2019
NCT02967549 Completed N/A Neurally Adjusted Ventilatory Assist vs Proportional Assist Ventilation November 2016 August 2018
NCT04077333 Completed N/A MISA to NRDS:a Multicenter Study in China July 1, 2017 March 30, 2019
NCT02999373 Completed Phase 2 Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm Neonates July 1, 2018 January 1, 2020
NCT03014453 Completed GER Poses a Potential Risk for Late Complications of BPD January 9, 2017 July 22, 2018
NCT04062136 Completed Phase 1 Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia March 1, 2019 November 30, 2020
NCT03041740 Completed Phase 1 Fluid Filled Lung Oxygenation Assistance Trial June 27, 2017 June 10, 2019
NCT03062709 Completed N/A A Study of Tobacco Smoke and Children With Respiratory Illnesses March 12, 2017 April 30, 2017
NCT03229967 Completed Gastrointestinal Microbiome Influence on the Development of Bronchopulmonary Dysplasia July 5, 2017 December 30, 2020
NCT03275415 Completed Phase 4 Intratracheal Budesonide/Surfactant Prevents BPD July 1, 2019 June 30, 2022
NCT03485703 Completed Phase 4 Azithromycin in the Prevention of Lung Injury in Premature Newborn August 28, 2012 April 13, 2016
NCT00000567 Completed Phase 3 High Frequency Ventilation in Premature Infants (HIFI) August 1984
NCT00000576 Completed Phase 3 Inhaled Beclomethasone to Prevent Chronic Lung Disease June 1993 April 1999
NCT00004669 Completed Phase 2 Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia June 1996
NCT00004785 Completed Phase 3 Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary Dysplasia November 1995
NCT00004805 Completed N/A Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death September 1991 August 1997
NCT00005287 Completed Late Sequelae of Bronchopulmonary Dysplasia July 1986 June 1989
NCT00005289 Completed Risk Factors in Bronchopulmonary Dysplasia (Newborn Lung Project) July 1987 July 2008
NCT00005293 Completed Antecedents of Bronchopulmonary Dysplasia December 1988 November 1990
NCT00005294 Completed Developmental Sequelae of Severe Chronic Lung Disorders July 1989 June 1995
NCT00005376 Completed Premature Birth and Its Sequelae in Women September 1993 August 1998
NCT00005683 Completed Clinical Interventions in Respiratory Distress Syndrome and Neonatal Lung Injury - SCOR in Lung Biology and Diseases in Infants and Children December 1986 November 1997
NCT00000548 Completed Phase 3 Inhaled NO in Prevention of Chronic Lung Disease March 2000 February 2006
NCT00006058 Completed Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns September 1996
NCT00006401 Completed Phase 3 Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants September 2000 October 2007
NCT03546543 Completed N/A The Effects of Position on the Oxygenation Instability of Premature Infants as Documented by SpO2 Histograms January 1, 2018 March 30, 2020
NCT03503994 Completed N/A Inhaled Corticosteroids for Treatment of Bronchopulmonary Dysplasia July 27, 2001 November 15, 2006
NCT03682575 Completed Work of Breathing in Premature Infants at Discharge November 10, 2020 February 28, 2023
NCT03373539 Completed Neurotrophin Expression in Infants as a Predictor of Respiratory and Neurodevelopmental Outcomes December 2014 August 2019
NCT03649932 Completed Phase 1 Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing September 25, 2018 June 21, 2021
NCT03385330 Completed N/A BPD Saturation TARgeting June 1, 2018 September 1, 2023
NCT03411018 Completed Respiratory Management of Preterm Infants and Bronchopulmonary Dysplasia January 1, 2012 December 31, 2017
NCT05621785 Enrolling by invitation Corticosteroid Use in Premature Babies and Lung Ultrasonografi Use in the Progression to Bronchopulmonary Dysplasia March 1, 2022 March 30, 2024
NCT05925075 Enrolling by invitation Point of Care Lung Ultrasound in Preterm Infants With Respiratory Distress April 17, 2023 April 1, 2025
NCT06443528 Not yet recruiting Comparison of Lung Ultrasound Scores With Clinical Models for Predicting Bronchopulmonary Dysplasia:A Multi-center Prospective Cohort Study June 1, 2024 June 30, 2029
NCT04035629 Not yet recruiting Phase 1 129Xe MRI in Pediatric Population With BPD August 1, 2023 December 31, 2024
NCT04696003 Not yet recruiting Phase 3 Treatment of Classic Mid-trimester PPROM by Means of Continuous Amnioinfusion January 1, 2021 May 30, 2025
NCT04862377 Not yet recruiting Phase 3 Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia. October 1, 2021 April 1, 2026
NCT05136235 Not yet recruiting N/A Pulmonary Hypertension in Extremely Preterm Infants January 2022 December 2025
NCT05629910 Not yet recruiting N/A NeO2Matic-Pilot Trial January 1, 2024 July 1, 2025
NCT05638568 Not yet recruiting N/A Fast Assessment of Surfactant Deficiency in Preterm Infants to Speed up Treatment July 1, 2024 January 1, 2029
NCT05898633 Not yet recruiting Phase 1 Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease December 2023 December 2024
NCT06342752 Not yet recruiting The Role of VOCs, Airway Mucins and Airway Microbiome in Bronchopulmonary Dysplasia April 2024 September 2027
NCT06373289 Not yet recruiting N/A Target Oxygen Ranges in Infants With Pulmonary Hypertension July 1, 2025 July 1, 2030
NCT05547139 Recruiting N/A Impact of Extended CPAP on Bronchopulmonary Dysplasia October 10, 2022 December 31, 2024
NCT03512158 Recruiting N/A Non-invasive Respiratory Support in Preterm Infants May 15, 2018 December 31, 2023
NCT04078906 Recruiting N/A SMOFlipid and Incidence of BPD in Preterm Infants December 16, 2019 October 2024
NCT04107701 Recruiting Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD July 22, 2019 July 31, 2025
NCT06279741 Recruiting Phase 1/Phase 2 Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants December 28, 2023 December 31, 2029
NCT03576885 Recruiting Phase 1/Phase 2 Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia July 15, 2019 December 1, 2024
NCT04239690 Recruiting N/A Preservation of Blood in Extremely Preterm Infants March 15, 2020 June 30, 2024
NCT04270045 Recruiting Forced Oscillometry in Infants With Bronchopulmonary Dysplasia February 6, 2020 December 2024
NCT04278404 Recruiting Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) March 5, 2020 July 2024
NCT03455686 Recruiting N/A Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease April 19, 2018 December 2024
NCT03657693 Recruiting MRI in BPD Subjects May 4, 2018 August 2025
NCT03372525 Recruiting N/A Invasive Ventilation Strategies for Neonates With Acute Respiratory Distress Syndrome Syndrome (ARDS) December 1, 2018 December 31, 2024
NCT04003857 Recruiting Phase 2 Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial July 5, 2019 June 30, 2027
NCT03346343 Recruiting N/A Pulmonary Function Using Non-invasive Forced Oscillometry December 6, 2017 May 2027
NCT06110481 Recruiting Reversibility of Bronchial Obstruction in Children Born Preterm April 1, 2021 December 1, 2025
NCT04785859 Recruiting Multiparametric Bronchopulmonary Prediction December 1, 2020 March 2024
NCT04821453 Recruiting N/A NAVA vs. CMV Crossover in Severe BPD September 13, 2021 October 2025
NCT04825197 Recruiting Phase 2 Late Surfactant After a Recruitment Maneuver in Extremely Low Gestational Age Newborns - LATE-REC-SURF Trial December 1, 2021 February 1, 2025
NCT06270199 Recruiting Phase 2 Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia. January 11, 2024 December 2026
NCT04905732 Recruiting N/A Nasal High-frequency Oscillatory Ventilation (NHFOV) for Ventilated Newborn Infants With BPD May 20, 2021 December 31, 2024
NCT03631420 Recruiting Phase 1 Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants October 26, 2018 July 31, 2027
NCT04984057 Recruiting N/A Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome August 1, 2021 December 31, 2024
NCT03253263 Recruiting Phase 2 A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants May 9, 2019 January 21, 2028
NCT03797183 Recruiting Genesis Electrical Impedance Tomography (EIT): A Preliminary Study May 3, 2019 November 30, 2024
NCT03142568 Recruiting Phase 2 Safety of Sildenafil in Premature Infants April 2, 2018 March 2025
NCT05285345 Recruiting Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease September 27, 2023 November 2025
NCT06000761 Recruiting N/A Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit November 23, 2023 December 20, 2026
NCT05446272 Recruiting N/A The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial August 3, 2022 March 31, 2027
NCT05446389 Recruiting N/A PAL to Improve Oral Feeding for Infants With Chronic Lung Disease June 8, 2022 December 31, 2024
NCT05568264 Recruiting N/A Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit October 1, 2022 December 31, 2026
NCT05618769 Recruiting N/A Towards Life-Long Healthy Lungs: A Multidisciplinary Follow-up Framework for Preterm Infants July 18, 2022 July 31, 2025
NCT06427642 Recruiting N/A Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases April 1, 2022 April 30, 2025
NCT05682807 Recruiting Phase 3 Effect of Caffeine Versus Probiotic on Preterm Neonates With Bronchopulmonary Dysplasia June 30, 2022 June 2025
NCT05711966 Recruiting N/A Comparison of INRECSURE and LISA in Preterm Neonates With RDS January 9, 2023 April 15, 2026
NCT05777512 Recruiting N/A Randomized Controlled Crossover Trial of Postpyloric Feedings to Improve Pulmonary Outcomes in High-risk Preterm Infants October 2024 February 2026
NCT05849077 Recruiting N/A Optimization of Saturation Targets And Resuscitation Trial (OptiSTART) February 26, 2024 April 1, 2029
NCT05898022 Recruiting Phase 4 Pragmatic Research on Diuretic Management in Early BPD Pilot August 17, 2023 September 30, 2025
NCT06421519 Recruiting Phase 1/Phase 2 Different Levels of BiPAP May 23, 2024 August 1, 2024
NCT05944055 Recruiting 25OH Vitamin D Overdoses and Risk of Bronchopulmonary Dysplasia or Death January 1, 2023 December 1, 2023
NCT05986032 Recruiting Respiratory Oscillometry for the Prediction of Bronchopulmonary Dysplasia July 15, 2023 September 24, 2024
NCT04890158 Suspended N/A Prone Versus Supine Positioning and the Impact on Bronchopulmonary Dysplasia in Very Low Birth Weight Infants. December 7, 2021 June 2024
NCT04619602 Suspended Phase 1 Inhaled Treatment for Bronchopulmonary Dysplasia August 1, 2024 September 1, 2025
NCT05030012 Terminated N/A Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants September 2, 2021 October 19, 2023
NCT03475264 Terminated MRI of Lung Structure and Function in Preterm Children September 1, 2018 March 20, 2024
NCT00308789 Terminated Phase 2 A Trial of Infant Flow Biphasic Nasal Continuous Airway Pressure (NCPAP) Versus Infant Flow NCPAP for the Facilitation of Extubation in Infants </= 1250 Grams April 2006 December 2009
NCT00215540 Terminated Phase 2 SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants. February 2005 July 2006
NCT01748045 Terminated Phase 2/Phase 3 Study of Inhaled Nitric Oxide (iNO) and Respiratory Outcomes in Late Preterm Infants March 2013 July 2014
NCT03542812 Terminated Early Phase 1 L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia July 30, 2019 August 31, 2022
NCT03532555 Terminated N/A Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia March 22, 2018 August 25, 2022
NCT04506619 Terminated Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants September 9, 2020 August 5, 2022
NCT00303082 Terminated Phase 3 Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity January 2006 August 2009
NCT03701074 Terminated Phase 2 Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus December 15, 2018 December 2, 2020
NCT00005777 Terminated Phase 3 Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE) February 1998 September 2002
NCT03857841 Terminated Phase 1 A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD October 9, 2019 May 20, 2021
NCT02524249 Terminated N/A Early Versus Late Caffeine for ELBW Newborns September 2015 June 2019
NCT00156572 Terminated Phase 3 Management of Hyponatremia in Preterm Infants on Diuretics April 2005 December 2007
NCT04274192 Terminated N/A Effect of Synchronized vs. Continuous HFNC Using NAVA on WOB in Infants With BPD December 9, 2020 January 28, 2021
NCT01329432 Unknown status Phase 4 Surfactant Administration During Spontaneous Breathing December 2010 December 2011
NCT03774537 Unknown status Phase 1/Phase 2 Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia March 1, 2019 December 31, 2021
NCT03850457 Unknown status Epidemiological Study for Bronchopulmonary Dysplasia (BPD) in China January 1, 2020 December 2022
NCT03873506 Unknown status Phase 1 Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia July 1, 2018 December 31, 2020
NCT03876704 Unknown status Phase 3 Effects of Fat-soluble Vitamins Supplementation on Common Complications and Neural Development in Very Low Birth Weight Infants January 29, 2019 December 31, 2020
NCT03961139 Unknown status N/A Continuous Versus Intermittent Bolus Feeding in Very Preterm Infants - Effect on Respiratory Morbidity December 3, 2019 December 2022
NCT04019106 Unknown status Phase 1/Phase 2 Budesonide With Intratracheal Surfactants in Extremely Preterm Infants October 15, 2019 January 15, 2021
NCT04050488 Unknown status Phase 4 Zinc Supplementation on Very Low Birth Weight Infant August 20, 2019 July 31, 2020
NCT03035214 Unknown status Phase 2 Study to Justify Steroid Use in Preterm Neonates to Prevent Bronchopulmonary Dysplasia February 19, 2017 December 31, 2017
NCT04184648 Unknown status Comparison of Classification Standards of BPD in Premature Infants June 1, 2020 June 29, 2022
NCT02523521 Unknown status N/A Impact of an Exercise Program for Children Aged 4 to 6 Years With Bronchopulmonary Dysplasia August 2015 November 2015
NCT04209088 Unknown status N/A Interest of Pulmonary Ultrasound to Predict Evolution Towards Bronchopulmonary Dysplasia in Premature Infants at Gestational Age Less Than or Equal to 34 Weeks of Gestation May 29, 2020 June 6, 2023
NCT04237844 Unknown status Clinic Features and Outcome of BPD (SGBPD) December 1, 2020 December 30, 2021
NCT02140580 Unknown status Phase 4 OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP December 2011 June 2022
NCT02050971 Unknown status Phase 1 Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates October 2010 December 2015
NCT04393337 Unknown status N/A Estimating Length of Endotracheal Tube Insertion Using Gestational Age or Nasal-Tragus Length in Newborn Infants June 15, 2020 December 2023
NCT04497740 Unknown status Follow-up Results of Newborns With Tracheostomy August 10, 2020 December 31, 2020
NCT04499196 Unknown status Glucocorticoids and Pulmonary Hypertension July 29, 2020 July 29, 2022
NCT04555889 Unknown status N/A The Impact of Lung Recruitment Maneuver in 24-32 Weekers, and the Incidence of Bronchopulmonary Dysplasia October 31, 2020 December 30, 2022
NCT01989442 Unknown status N/A Nasal Mask and Prong Use in Non-invasive Ventilation for Newborns November 2013 January 2015
NCT01959009 Unknown status N/A High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Blood Oxygenation and Stability of Oxygenation August 2014 June 2022
NCT01721655 Unknown status Phase 2/Phase 3 Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease October 2012 December 2016
NCT01652118 Unknown status Phase 3 Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma Hominis October 2011 January 2013
NCT01373008 Unknown status Phase 2 Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD) June 2011 June 2016
NCT03601416 Unknown status Phase 2 Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia July 1, 2019 December 31, 2021
NCT01268215 Unknown status Phase 2 Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants. July 2010 December 2013
NCT01207869 Unknown status Phase 1 Intratracheal Umbilical Cord-derived Mesenchymal Stem Cells for Severe Bronchopulmonary Dysplasia July 2010 July 2012
NCT05181319 Unknown status Prediction for Bronchopulmonary Dysplasia January 1, 2018 December 1, 2022
NCT00904774 Unknown status Genetic Susceptibility for Bronchopulmonary Dysplasia in Preterm Infants May 2009
NCT00254176 Unknown status Phase 2/Phase 3 Cysteine Supplementation in Critically Ill Neonates September 2006 July 2011
NCT03521063 Unknown status Phase 4 Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia. January 1, 2018 December 31, 2019
NCT03538977 Unknown status N/A Hydrotherapy in Premature Infants With Bronchopulmonary Dysplasia October 11, 2018 December 2019
NCT03558334 Unknown status Phase 1 Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia June 28, 2018 June 30, 2022
NCT01895075 Withdrawn Phase 2 Inhaled Budesonide for Non-ventilated Infants at High Risk of Bronchopulmonary Dysplasia: the i-BUD Pilot Study January 1, 2019 September 1, 2020
NCT03645525 Withdrawn Phase 1/Phase 2 Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD) December 1, 2019 April 1, 2023
NCT02282176 Withdrawn Phase 3 TINN2: Treat Infection in NeoNates 2 January 2015 January 2018
NCT02996162 Withdrawn Hypercapnia and Its Association With Long-term Respiratory Morbidities in Premature Infants With Chronic Lung Disease December 1, 2020 May 6, 2021
NCT00742534 Withdrawn Phase 1 Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants August 2008 August 2009
NCT05053269 Withdrawn Body Weight Growth After Birth and Bronchopulmonary Dysplasia October 1, 2021 December 31, 2024
NCT03378063 Withdrawn Early Phase 1 Stem Cells for Bronchopulmonary Dysplasia November 1, 2017 December 30, 2022
Disase is a (Disease Ontology)
DOID:850
Cross Reference ID (Disease Ontology)
ICD10CM:P27.1
Cross Reference ID (Disease Ontology)
MESH:D001997
Cross Reference ID (Disease Ontology)
NCI:C90599
Exact Synonym (Disease Ontology)
Bronchopulmonary dysplasia of newborn
Exact Synonym (Disease Ontology)
Chronic lung disease of prematurity
Exact Synonym (Disease Ontology)
Neonatal chronic lung disease
Exact Synonym (Disease Ontology)
neonatal chronic respiratory disease
Exact Synonym (Disease Ontology)
Perinatal bronchopulmonary dysplasia
Exact Synonym (Disease Ontology)
Respiratory insufficiency
OrphaNumber from OrphaNet (Orphanet)
70589
MeSH unique ID (MeSH (Medical Subject Headings))
D001997